Trade

Brawn Biotech share price

High risk
  • 64%Low risk
  • 64%Moderate risk
  • 64%Balanced risk
  • 64%High risk
  • 64%Extreme risk
  • 21.40(0.00%)
    April 16, 2026 16:00:01 PM IST
    • NSE
    • BSE
  • Vol : 0 (NSE + BSE)
    Last 20 day avg : 0.96 K

Brawn Biotech is trading 0.00% upper at Rs 21.40 as compared to its last closing price. Brawn Biotech has been trading in the price range of 0.00 & 0.00. Brawn Biotech has given -0.51% in this year & 4.49% in the last 5 days. The company posted a net profit of 0.05 Crores in its last quarter.Listed peers of Brawn Biotech include Sun Pharmaceutical Industries (-0.43%), Divi's Laboratories (0.62%), Torrent Pharmaceuticals (0.15%).The Mutual Fund holding in Brawn Biotech was at 0.35% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Brawn Biotech was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Apr 20, 2026, 01:18 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.02
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.00
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
0.00
Highest
0.00
52 week range
Lowest
15.70
Highest
24.37
Brawn Biotech Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bearish
1,668.00-0.434,00,199.6435.345.630.970.50
Divi's Laboratories
Neutral
6,267.600.621,66,341.0270.8610.390.510.01
Torrent Pharmaceuticals
Bullish
4,185.000.151,41,292.2370.0117.780.8817.62
Lupin
Bullish
2,326.800.111,06,507.0331.076.040.5311.80
Dr Reddy's Laboratories
Moderately Bearish
1,229.50-0.481,02,318.1217.913.020.662.34
Brawn Biotech Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-14Quarterly Results
2025-08-13Quarterly Results
2025-05-26Audited Results
2025-02-12Quarterly Results
2024-11-14Quarterly Results
About the company Brawn Biotech
  • IndustryBiotechnology & Drugs
  • ISININE899B01015
  • BSE Code530207
  • NSE Code
Brawn Biotech Limited is an India-based integrated healthcare company. The Company's pharmaceutical products cover all product segments, such as Antibacterials, Cardiovasculars, Antidiabetics, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarials, And Nutritionals. Its products include Sefix-400 Capsules, Sefix-200 Capsules, Celevran Cream W/C (25GM), Voltran Gel W/C (25GM), Folic Acid Tablets 8P 5MG, Ponstran Capsules 250MG, Fugeran Cream W/C (15GM), Stopin Tablets, Cefixime Tablets 100MG (1*10), Cefixime Tablets USP 200MG (1*10), Carbramazepine 200 MG IP Tab, Potassium Chloride for Injection 15% 150mg/ml USP (10 ML), Promethazine HCL Injection 25 MG/ML, Allopurinol 100mg IP Tab, Carbamazepine 100 mg IP Tab, Feme Tab, Bromex Liquid, Salbutamol 4 mg IP Tab, Chlorpheniramine Maleate 4mg Tab, Pheniramine Maleate 25mg Tab, Eracef 500 mg, Erazide 1 Gm Injection, Hyoscine Butyl Bromide (1 ml) IP Inj, Alprazolam 0.5 Mg Tab, and others.
  • Management Info
  • Priyanka SharmaCompliance Officer, Company Secretary
  • Amit KumarManager
Brawn Biotech Share Price FAQs

Brawn Biotech is trading at 21.40 as on Thu Apr 16 2026 10:30:01. This is 0.00% upper as compared to its previous closing price of 21.40.

The market capitalization of Brawn Biotech is 6.42 Cr as on Thu Apr 16 2026 10:30:01.

The 52 wk high for Brawn Biotech is 24.37 whereas the 52 wk low is 15.70

Brawn Biotech can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 30.29
  • Dividend Yield: 0.00%
  • D/E ratio: -

Brawn Biotech reported a net profit of -1.74 Cr in 2025.

The Mutual Fund Shareholding was 0.35% at the end of 31 Mar 2026.